| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0e688f4f0f360c3093469970677fdbe |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-3262 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-344
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_889f662a9b2d904efd4d4568c2a63fd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df04514c5bc746b34bec0066633885fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b464560aed1744784ffb680a264b425f |
| publicationDate |
2006-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-100631073-B1 |
| titleOfInvention |
Composition for the prevention and treatment of alcoholic liver disease and alcoholic hyperlipidemia comprising the deodeok extract |
| abstract |
The present invention relates to a composition for the prevention and treatment of alcoholic liver disease and alcoholic hyperlipidemia comprising a deodeok extract as an active ingredient.n n n The composition according to the present invention has the effect of reducing the lipid concentration, lipid peroxide concentration of the liver tissue and plasma increased due to the ingestion of alcohol and normalizing the activity of the liver function indicator enzyme, thus preventing, reducing and reducing alcoholic liver disease and alcoholic hyperlipidemia. It can be usefully used for the purpose of treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100814382-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101344055-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101290749-B1 |
| priorityDate |
2006-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |